Search clinical trials for: Lutetium Lu 177 dotatate

Total 182635 results

R-Pharm

Completed

Phase I Combination Ixabepilone + Cisplatin

Non Small Cell Lung Cancer

United States, Italy
ResMed

Terminated

A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b (ComfortCOPD)

Chronic Obstructive Pulmonary Disease

Germany
Y-mAbs Therapeutics

Not yet recruiting

Phase 1, Open-label, Dose-escalation Trial With CD38-SADA:177 Lu-DOTA Drug Complex in Patients With Relapsed or Refractory Non-Hodgkin Lymphoma

Non-hodgkin Lymphoma

United States
Grupo Espanol de Tumores Neuroendocrinos
MFAR; ITM Oncologics GmbH

Recruiting

Efficacy and Safety of Radiotherapy Compared to Everolimus in Somatostatin Receptor Positive Neuroendocrine Tumors of the Lung and Thymus. (LEVEL)

Thymus Neoplasms | Neuroendocrine Tumors | Lung Neuroendocrine Neoplasm

Spain, Italy, France
King's College London
Guy's and St Thomas' NHS Foundation Trust

Recruiting

Optimising Molecular Radionuclide Therapy (SELFIE)

Hyperthyroidism | Neuroendocrine Tumors | Thyroid Carcinoma | Thyroid Cancer

United Kingdom
Dana-Farber Cancer Institute
Novartis

Recruiting

LuCarbo - a Study of 177Lu-PSMA-617 Plus Carboplatin in Metastatic Castrate-resistant Prostate Cancer

Prostate Cancer | Metastatic Prostate Cancer | Metastatic Castration-resistant Prostate Cancer

United States
Nordic Nanovector

Withdrawn

Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)

Non-Hodgkin Lymphoma

Germany
Aarhus University Hospital Skejby

Recruiting

Association Between Radial Artery Intervention and Development of Neuropathy in the Hand - A Prospective Study (ACCESS-IV)

Carpal Tunnel Syndrome | Ischemic Heart Disease | Nerve Injury

Denmark
University of California, San Francisco

Completed

Adherence-Suppression-Resistance Relationships for Atripla Compared to Historical Antiretroviral Regimens

HIV Infections | Adherence
Seoul National University Hospital

Unknown

Clinical Implication of the Tunable Crack Sensor

Blood Pressure

Korea, Republic of
Misr International University

Recruiting

Clinical Evaluation of Self-Adhesive Bulk-Fill Composite Versus Conventional Nano-hybrid Composite in Cervical Cavities

Cervical Caries

Egypt
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

DCNN Developed for Detection and Assessing the Perfusion of PTG

Thyroidectomy

China
University Hospital Heidelberg
Health Economics and Health Care Management, Bielefeld University; Chair of... and other collaborators

Completed

Financial Effects of a Tumor Disease - Development and Validation of a Patient Reported Outcome Measure in Germany (FIAT)

Cancer

Germany
Sunnybrook Health Sciences Centre
University Health Network, Toronto; University of Toronto; West Park Healthcare... and other collaborators

Completed

Building Capacity in the System to Support Persons With Stroke and Cognitive Impairment (CO-OP_KT)

Stroke

Canada
UConn Health
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Contingency Management to Reduce Alcohol Use in a Soup Kitchen Sample (SK)

Contingency Management | Alcohol Abuse

United States
University Hospital of North Norway

Unknown

Audiometric Parameters in Conductive Hearing Loss and Middle Ear Disease

Otosclerosis | Tympanic Membrane Perforation

Norway
National University Hospital, Singapore

Unknown

ALPI vs Medical Therapy Effects on Optic Nerve Structure & Function (Iridoplasty)

Glaucoma

Singapore
Bispebjerg Hospital

Completed

Photodynamic Therapy of Acne Vulgaris - a Randomized Blinded Controlled Study

Acne Vulgaris

Denmark
Fernanda Yanez Regonesi
American Academy of Dental Sleep Medicine

Recruiting

Mandibular Advancement Device and Changes in Nocturia (MAD)

Obstructive Sleep Apnea | OSA | Nocturia

United States
University Hospital, Basel, Switzerland
Swiss Cancer League

Recruiting

Treatment of Recurrent or Progressive Meningiomas With the Radiolabelled Somatostatin Antagonist 177Lu-satoreotide (PROMENADE)

Meningioma

Switzerland
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Recruiting

Pre-warning Risk Scoring System for Sudden Cardiac Death

Sudden Cardiac Death

China
Ain Shams University

Recruiting

Noninvasive Hemoglobin Monitoring by Spectrophotometry in Blunt Abdominal Trauma Patients for Conservative Management

Intensive Care Unit

Egypt
Chinese PLA General Hospital

Completed

Low Dose Ruxolitinib in Combination With Methylprednisolone

Stem Cell Transplant Complications | aGVHD

China
Sidney Kimmel Cancer Center at Thomas Jefferson...

Completed

Study on the Safety and Effectiveness of VELCADE® in the Treatment of Graft-Versus-Host Disease

Graft-versus-Host Disease

United States
Seoul National University Hospital

Completed

Low-Dose Coronary Computed Tomographic Angiography for Early Triage of Acute Chest Pain

Chest Pain

Korea, Republic of
Mathematica Policy Research, Inc.

Completed

Randomized Experiment of Playworks

Focus on Physical Activity, Recess, and Play

United States
The University of Hong Kong

Completed

Effectiveness of Dental Trauma Educational Poster to Secondary Students

Injuries

Hong Kong
Jonsson Comprehensive Cancer Center

Not yet recruiting

Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)

Prostate Carcinoma | Stage IVB Prostate Cancer American Joint Committee on Cancer (AJCC) v8

United States
Mayo Clinic

Recruiting

Schedule De-Escalation of 177Lu-PSMA-617 for the Treatment of Metastatic Castrate Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8

United States
Istituto Scientifico Romagnolo per lo Studio e...

Unknown

177Lutethium - Peptide Receptor Radionuclide Therapy (Lu-PRRT) Plus Capecitabine Versus Lu-PRRT in FDG Positive, Gastro-entero-pancreatic Neuroendocrine Tumors (Lu-Ca-S)

Gastro-entero-pancreatic Neuroendocrine Tumors

Italy
Pfizer

Completed

Real World Evidence Study on Metastatic Prostate Cancer in the Pirkanmaa Hospital District in Finland

Metastatic Castration Resistant Prostate Cancer (mCRPC) | Metastatic Castration Sensitive Prostate Cancer (mCSPC)

Finland
Bristol-Myers Squibb

Completed

Regimen Optimization Study

Kidney Transplantation

United States, Argentina
Cairo University

Completed

Clinical Outcomes of Zirconia-reinforced Lithium Silicate Partial Coverage Crowns Compared to Lithium Disilicate Partial Coverage Crowns

Partial Coverage Restoration

Egypt
RWTH Aachen University

Unknown

Effect of the Topical Application of Anaesthetics With EnkFiberoptic Atomizer During the Bronchoscopy (EnkAtomizerII)

Flexible Bronchoscopy

Germany
Tel-Aviv Sourasky Medical Center

Unknown

A Prospective Clinical and Radiographic Assessment on New Platform-switched Laser Lok Implants

Preserve Crestal Bone Level and Gingival Margin Around Dental Implants

Israel
National Institute of Allergy and Infectious Diseases...

Completed

Prophylaxis Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

HIV Infections | Tuberculosis

United States
Jonsson Comprehensive Cancer Center
Novartis Pharmaceuticals

Not yet recruiting

Re-treatment With 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer, RE-LuPSMA Trial

Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8

United States
Novartis Pharmaceuticals
Alliance Foundation Trials, LLC.; RTOG Foundation, Inc.

Active, not recruiting

An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With SoC, Versus SoC Alone, in Adult Male Patients With mHSPC (PSMAddition)

Prostatic Neoplasms

United States, China, Canada, Spain, United Kingdom, Belgium, Japan, Taiwan, Germany, Singapore, Austria, Netherlands, Korea, Republic of, France, Switzerland, Denmark, Sweden, Poland, Czechia
National Institute of Allergy and Infectious Diseases...
Lederle Laboratories; Hoechst Marion Roussel

Completed

Preventive Treatment Against Tuberculosis (TB) in Patients With Human Immunodeficiency Virus (HIV) Infection and Confirmed Latent Tuberculous Infection

HIV Infections | Tuberculosis

United States, Puerto Rico
Barbara Ann Karmanos Cancer Institute
National Cancer Institute (NCI)

Terminated

Gene Expression Levels in Predicting Treatment Response in Patients With Stage IV Non-small Cell Lung Cancer

Recurrent Non-small Cell Lung Cancer | Stage IV Non-small Cell Lung Cancer

United States
Ipsen

Terminated

Study to Assess the Efficacy of Brachytherapy With or Without Hormone Therapy, Using Triptorelin 22.5mg in Patients With Recurrence of Prostate Cancer (ANABRAQ)

Prostate Cancer

Spain
University College, London
Roche Pharma AG; Cancer Research UK

Terminated

WBRT & Erlotinib in Advanced NSCLC and Brain Metastases (TACTIC)

Lung Cancer | Metastatic Cancer

United Kingdom
University of Washington
Novartis; Institute for Prostate Cancer Research (IPCR)

Not yet recruiting

Vorinostat and 177Lu-PSMA-617 for the Treatment of PSMA-Low Metastatic Castration-Resistant Prostate Cancer

Castration-Resistant Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Metastatic Prostate Adenocarcinoma

United States
Novartis Pharmaceuticals

Active, not recruiting

A Study of 177Lu-FAP-2286 in Advanced Solid Tumors (LuMIERE) (LuMIERE)

Solid Tumor

United States
ANRS, Emerging Infectious Diseases
Institut National de la Santé Et de la Recherche Médicale, France

Recruiting

Dual Therapy in HIV Patients in 4 Days a Week Versus 7 Days a Week

HIV Infections

France, Martinique
City, University of London
Royal Free Hospital NHS Foundation Trust

Completed

A Randomised Control Trial of Integrative Cognitive Behavioural Therapy for Alopecia

Alopecia

United Kingdom
Catholic University of the Sacred Heart

Completed

IPHC in Patients With Platinum-sensitive Recurrent Ovarian Cancer (IPHC)

Ovarian Epithelial Cancer Recurrent
M.D. Anderson Cancer Center
Telix Pharmaceuticals Limited

Active, not recruiting

Phase 1b/2 Study of Combination 177Lu Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients With Advanced Clear Cell RCC

Clear Cell Renal Cell Carcinoma | Advanced Cancer

United States
University of California, Davis
National Cancer Institute (NCI)

Completed

Erlotinib and Cetuximab in Treating Patients With Advanced Solid Tumors With Emphasis on Non-Small Cell Lung Cancer

Lung Cancer | Unspecified Adult Solid Tumor, Protocol Specific

United States
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon Alfa in Treating Patients With Recurrent Ovarian Cancer

Ovarian Cancer | Primary Peritoneal Cavity Cancer

United States

Search clinical trials for: Lutetium Lu 177 dotatate

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in South Africa

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations